Finpati, Hyderabad (2026)

06/03/2025

Aditya Birla Capital (ABCAPITAL-EQ) – Multi-Timeframe Technical Analysis

Key Observations (Long-Term & Weekly Chart)
1. Trend & Price Action
• Strong Sell-off from 246.90 highs, now at 160.34.
• Falling below 200 EMA, indicating long-term weakness.
• Downtrend intact but showing potential bottoming signs.
2. Support & Resistance Levels
• Support:
• Fib 0.5 at 141.13 – Major retracement level.
• Fib 0.618 at 117.40 – Strong demand zone.
• Volume profile support ~120.
• Resistance:
• 166.85 (Fib 0.382) – Immediate resistance.
• 197.45 (Fib 0.236) – Major supply zone.
3. RSI & Momentum
• Bearish RSI trend, but forming a bullish divergence (possible trend reversal signal).
• RSI nearing oversold levels, increasing potential for a rebound.
4. Volume Profile & Market Structure
• High volume node at 200-220, confirming strong resistance above.
• Thin volume below 140, meaning a break of 140 can lead to a sharp fall.
5. Outlook & Strategy
• Short-term relief rally possible towards 166-185 if RSI breaks out.
• Sustained move below 140 may trigger a deeper correction to 117-120.
• Reversal confirmation above 185 with strong volume.

📉 Bearish bias continues, but signs of exhaustion. Watch for reversal patterns & volume breakout!

Follow my market views on https://front.page/

06/03/2025

Asian Paints (ASIANPAINT) Weekly Chart – Technical Analysis & WW Target ₹4000

1. Key Price Action & WW Strategy
• Stock is trading at ₹2237.60, rebounding from ₹2222 (1.618 Fib support).
• A falling wedge pattern is visible, indicating a potential reversal.
• Wolfe Wave (WW) EPA line suggests a long-term target of ₹4000 if the pattern plays out.

2. Support & Resistance Levels
• Support: ₹2222 (Fib 1.618), ₹2090 (major long-term support).
• Resistance: ₹2276 → ₹2383 → ₹2876 (key volume node).

3. RSI & Momentum Indicators
• RSI (32.71) shows bullish divergence, signaling potential upward momentum.
• A break above ₹2383 could confirm strength, targeting ₹2876+.

4. Trading Strategy

✅ Short-Term (Reversal Setup)
• Breakout Entry: Above ₹2383 → Targets ₹2876 → ₹3394.
• Stop-loss: ₹2220 (below support zone).

✅ Long-Term (WW Target ₹4000)
• Accumulate in ₹2200-2250 range.
• Confirm bullish trend above ₹2876 for sustained move.

📌 Key Watch:
• Hold above ₹2276 and RSI moving past 40-50 for bullish confirmation.
• Breakout above ₹2876 strengthens case for ₹4000 long-term target.

Follow my market views on https://front.page/

04/03/2025

Jio Financial Services - Weekly Technical Analysis
1. Trend: Strong downtrend with lower highs/lows. Moving averages confirm bearish momentum.
2. Key Levels:
• Support: 200.92, then 171-168 (Fibo 3.618) and 138-136 (Fibo 4.236).
• Resistance: 218-224, 243-246, 267-277 (Fibo + volume profile).
3. Fibonacci & Volume:
• Price broke 2.618 level (218-224); likely heading to 171-168.
• High volume at 243-246, low volume below 200 may lead to rapid moves.
4. RSI: Oversold, but can stay low in strong downtrends.
5. Trade Scenarios:
• Bearish: Below 218, likely drop to 170-180.
• Bullish: Needs 224+ breakout, stronger above 243-246.
• Long-term Reversal: Only above 267.

Conclusion:
• Bias: Bearish unless 224+ reclaimed.
• Strategy: Watch for reversal signals or buy near key supports.

Follow my market views on https://front.page/

13/02/2025

• Bullish Case: If price holds 1140-1160 and RSI continues to rise, we may see a short-term reversal towards 1250-1300.
• Bearish Case: If price breaks below 1140, we could see further downside towards 1100 or lower.
• Wait for Confirmation: Monitor volume, RSI movement, and price action at key levels before taking a position.

Follow my market views on https://front.page/

05/01/2025

MTAR Technologies Limited is a precision engineering company based in Hyderabad, India, specializing in manufacturing critical components for sectors such as clean energy, civil nuclear energy, aerospace, and defense.

Key Financial Metrics (as of March 2024):
• Revenue: ₹580.75 crore
• Net Profit: ₹54.16 crore
• Earnings Per Share (EPS): ₹17.6
• Price-to-Earnings (P/E) Ratio: Approximately 94.8
• Debt-to-Equity Ratio: 0.28
• Return on Equity (ROE): 8.66%
• Operating Profit Margin: 19%
• Net Profit Margin: 16.1%

Recent Developments:
• Order Acquisition: In December 2024, MTAR Technologies secured new orders worth ₹2.3 billion, indicating robust demand for its products and services.

Valuation Considerations:
• The company’s P/E ratio stands at approximately 94.8, suggesting a high valuation relative to its earnings.
• Analysts have noted that MTAR operates with high earnings multiples, indicating that the stock may be overvalued compared to industry peers.

Growth Prospects:
• MTAR has demonstrated consistent revenue growth, with a compound annual growth rate (CAGR) of 15.07% over the past five years.
• The company has diversified its revenue streams across various high-growth sectors, including clean energy and aerospace.

Risks and Considerations:
• High customer concentration, with two clients accounting for 73% of revenues in FY22, poses a potential risk.

• The company’s high valuation multiples may limit upside potential and could be susceptible to market corrections.

Follow my market views on https://front.page/

13/12/2024

CreditAccess Grameen Limited: Fundamental Analysis and SWOT
Stock Snapshot
• Current Price (Dec 2024): ₹903.40
• 52-Week High/Low: ₹1,796 / ₹900
• FY23 Revenue Growth: ₹29.94 billion (+54.57% YoY)
• Net Income Growth: ₹14.46 billion (+75.04% YoY)

Recent Developments
• Raised ₹390 crore via co-financing with DEG (€25 million) and Citi (₹170 crore).

SWOT Analysis

Strengths
• Strong Financial Performance: Robust revenue and net profit growth.
• Market Position: Diverse microfinance offerings cater to underserved segments.

Weaknesses
• Stock Decline: 49.70% fall from its 52-week high.
• Degrowth: Q-o-Q dip in revenue, profits, and operating margins.

Opportunities
• Financial Inclusion: Growth potential in underserved rural markets.
• Digital Transformation: Opportunity to enhance efficiency and outreach.

Threats
• Regulations: Microfinance-specific policy changes may impact margins.
• Competition: Rising challenges from NBFCs and traditional banks.

Conclusion
CreditAccess Grameen remains a key player in microfinance with strong financial fundamentals, despite recent stock volatility. Focus on digital and rural expansion can drive long-term growth.

Follow my market views on https://front.page/

11/11/2024

CMP 436
Already gave call before.. gave 50% returns. Now again available at a good price.

Buy 50% now and then add remaining if 360 comes for the target of 1500 by 2029

Follow my market views on https://front.page/

03/10/2024

Company Overview

Paushak Ltd, part of the Alembic Group, specializes in phosgene-based specialty chemicals, serving diverse sectors like pharmaceuticals, agrochemicals, and dyes. The company is debt-free, which strengthens its balance sheet and future growth prospects. It has maintained consistent profitability, even with recent market fluctuations.

Current Stock Details

• CMP: ₹5,508.45
• 52-week High/Low: ₹6,410 / ₹4,464
• P/E Ratio: 30.57 (Lower than sector peers, making it an attractive valuation)
• EPS: ₹180.17 (FY 2024)
• Promoter Holding: 66.97% (Alembic Ltd holds 19.07%, Nirayu Ltd holds 41.15%) .

Recent Performance & Trends

Paushak’s stock has declined by 13.26% over the last year due to overall market volatility but is fundamentally sound. The company’s operating margins remain strong at 35%, and its net profit has grown to ₹54 crore, driven by demand in its key sectors .

Recent News & Product Developments

1. Growth in Phosgene Derivatives: Paushak continues to expand its product lines in phosene-based chemicals, essential for the pharmaceutical and agrochemical industries. This market is expected to grow, driven by increased demand for high-purity intermediates.
2. Management Commentary: The leadership, led by Chairman Chirayu Amin, is focused on capacity expansion and operational efficiency, which positions the company to capture future growth .

Analyst Commentary

Market analysts are bullish on Paushak due to its leadership in niche chemicals and long-term growth potential in high-margin sectors like pharmaceuticals and agrochemicals. The stock is also seen as undervalued compared to its industry peers .

Finpati Buy Recommendation

• First Tranche (30%): Buy at CMP of ₹5,500.
• Second and Final Tranche: Buy only if the price corrects to ₹3,750.
• Target Price: ₹15,000 by 2030, representing a strong growth opportunity as the company scales up its capacity and taps into growing demand in its sectors .

Follow my market views on https://front.page/

05/09/2024

Cmp 1777
Kotak needs some air to breathe.. can it break out? And it’s breakout from suffocation takes the BNF to 55k?

Follow my market views on https://front.page/

05/09/2024

CMP 470
Add more if it comes to 401
And more at 376
SL 350
Target 5X

IOLCP Complete Analysis Summary:

1. Company Overview: IOL Chemicals and Pharmaceuticals (IOLCP) is a leading API manufacturer, especially known for being one of the largest global producers of Ibuprofen. The company also produces specialty and organic chemicals.
2. Financial Performance: IOLCP has shown strong revenue growth, driven by high demand for Ibuprofen and an expanding API portfolio. The company maintains healthy profit margins thanks to its integrated production model, allowing for cost efficiency. It has low debt and strong cash flow, supporting ongoing expansion efforts.
3. Market Position: The company has a competitive edge due to its leadership in Ibuprofen production and its strategic focus on expanding into new markets, particularly regulated international ones. This reduces dependency on the domestic market and increases growth opportunities.
4. SWOT Analysis:
• Strengths: Market leader in Ibuprofen, strong financials, integrated production.
• Weaknesses: High reliance on Ibuprofen, limited diversification.
• Opportunities: Expanding product range, entering new markets.
• Threats: Regulatory risks, competition, raw material costs.
5. Peer Comparison: Compared to peers like Divi’s Laboratories and Laurus Labs, IOLCP has a strong market position but is less diversified. Its integrated model and expansion strategies provide a competitive advantage in cost and market reach.
6. Technical Analysis: Currently, IOLCP shows a bullish trend if trading above key moving averages (50-day and 200-day). Watch for support levels for potential entry points and be cautious of resistance levels for selling.

Call to Action: IOLCP is a solid investment for long-term growth, supported by strong fundamentals and strategic expansion. Monitor market conditions, especially regulatory changes and raw material costs. Consider buying if the stock shows bullish momentum and is near support levels.

Follow my market views on https://front.page/

22/08/2024

Cmp 753

ONLY FOR EDUCATIONAL PURPOSE. Not a RECOMMENDATION.

JNK India is a leading player in the heating equipment industry, particularly in designing, manufacturing, and commissioning process fired heaters, steam/hydrogen reformers, and cracking furnaces.

The company caters to various sectors like oil and gas refineries, petrochemicals, fertilizers, and renewable energy, reducing dependency on a single industry.

Concern : trading at high PE already.
Any downturn in key sectors like oil and gas could adversely affect its business.

Finpati view
Cmp 753
We shall Add more if it comes to 612
More at 548
We shall Target 10x
In the timeframe of 6 to 7 years

Follow my market views on https://front.page/

16/08/2024

Cmp 1366
Add more if it comes to 1220
SL 1180
Target 2700
Time frame 4 years

Follow my market views on https://front.page/

Finpati

06/03/2025

06/03/2025

04/03/2025

13/02/2025

05/01/2025

13/12/2024

11/11/2024

03/10/2024

05/09/2024

05/09/2024

22/08/2024

16/08/2024

Address

Telephone

Website

Alerts

Contact The Business

Shortcuts

Share